MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)

    Objective: We assume that the cerebrovascular disease might influence on the course and clinical features of dementia with Lewy bodies (DLB). The aim of this…
  • 2016 International Congress

    Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

    H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…
  • 2016 International Congress

    Neuro-cognitive domain related to conversion of Parkinson’s disease dementia

    S.M. Cheon, S.Y. Lee, J.W. Kim (Busan, Korea)

    Objective: To identify neurocognitive domain and mild cognitive impairment (MCI) subtype associated with conversion from non-demented patients with Parkinson's disease (PD) and PD-MCI to dementia…
  • 2016 International Congress

    Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment

    R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris (London, United Kingdom)

    Objective: To demonstrate quantifiable differences in cortical visual processing in patients with Parkinson's disease with no evidence of dementia, as compared to controls. Background: Visual…
  • 2016 International Congress

    Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder

    U. Suenkel, S. Heinzel, A.K. von Thaler, F. Metzger, G.W. Eschweiler, I. Liepelt-Scarfone, W. Maetzler, D. Berg (Tübingen, Germany)

    Objective: To evaluate potential differences in cognitive, motor and demographic factors between individuals who are lost to follow-up in the longitudinal Tuebinger evaluation of Risk…
  • 2016 International Congress

    Apraxia in Parkinson’s disease

    M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: We aim to study apraxia in Parkinson's disease. Background: Limb apraxia is a cognitive motor disorder of skilled, purposive movements not caused by elementary…
  • 2016 International Congress

    Novel training based on declarative memory cues improves gait perfromance in patients with Parkinson’s disease: A randomized clinical trial

    M.E.P. Piemonte, E. Okamoto, K.R. Cardoso, T.P. Oliveira, C.S. Miranda, M. Pikel, F. Mendes, G.F. Xavier (Sao Paulo, Brazil)

    Objective: To verify the long-term efficiency of a new strategy based on declarative memory cues to improve the gait performance and independence in activities of…
  • 2016 International Congress

    Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan

    Y.F. Chen, C.C. Chang, W.F. Chen, F.Y. Shih, M.Y. Lan, T.K. Lin, Y.F. Chen, Y.Y. Chang (Kaohsiung, Taiwan)

    Objective: To demonstrate cognitive outcome after subthalamic deep brain stimulation(DBS) in the patients with Parkinson's disease(PD) in Taiwan. Background: Deep brain stimulation of the subthalamic…
  • 2016 International Congress

    The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

    S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

    Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
  • 2016 International Congress

    Parkinson’s disease characteristics in patients with Gaucher’s disease

    A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)

    Objective: To assess the phenotype of Parkinson's disease (PD) patients in homozygote or compound heterozygote carriers of mutations in the β-glucocerebrosidase gene (GBA). Background: Gaucher's…
  • « Previous Page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley